BioSpace News Archive

Deals

ArunA Bio Raises $13 Million in Common Stock Financing

Financing proceeds to advance ArunA Bio’s neural exosome therapies for neurodegenerative diseases and partnering activities

July 24, 2019
·
4 min read
Bio NC

Mississippi Baptist Medical Center Patient Education and Meds-to-Beds Program Improves Patient Health

TeleHealth Services Helps Hospital Build Strong Relationships of Trust with Patients and Families

July 24, 2019
·
4 min read
Business

The Medicines Company Reports Second-Quarter 2019 Financial Results and Updates Clinical Development Program

The Medicines Company reported financial results for the second quarter that ended June 30, 2019. Second quarter highlights included significant progress with the clinical development program for inclisiran and the completion of a public offering of common stock.

July 24, 2019
·
11 min read
Business

IQVIA Reports Second-Quarter 2019 Results, Raises Full-Year Revenue and Adjusted Diluted EPS Guidance

IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, reported financial results for the quarter ended June 30, 2019.

July 24, 2019
·
11 min read
Global Bay Leaf Market 2019-2023 | Increasing Popularity of Organic Bay Leaf to Boost Growth | Technavio

The global bay leaf market is expected to post a CAGR close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

July 24, 2019
·
4 min read
Biotech Bay

New Data Demonstrating Benefits of Accuray Software Solutions Presented at the Annual Meeting of the American Association of Physicists in Medicine

Accuray Incorporated (NASDAQ: ARAY) announced today that studies validating the benefits of CyberKnife® and Radixact® System software innovations were shared by prominent physicists at the recent 61st annual meeting of the American Association of Physicists in Medicine (AAPM).

July 24, 2019
·
6 min read
Biotech Bay

Invitae Launches Detect Programs to Make it Easier for Patients to Get Genetic Testing for Prostate Cancer, Muscular Dystrophy and Heart Conditions

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of its Detect programs to provide no-charge genetic testing for conditions in which testing is underutilized and can improve diagnosis and treatment

July 24, 2019
·
6 min read
Business

Pathnostics Announces CEO Appointment

Fast-Growing Company Engages Experienced Laboratory Services Leader to Continue Expansion

July 24, 2019
·
2 min read
Pharm Country

Celgene and the Multiple Sclerosis Association of America Bring MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to Festival to Raise Awareness of Multiple Sclerosis and Brain Health

Celgene Corporation (NASDAQ: CELG) and the Multiple Sclerosis Association of America (MSAA) are bringing the MS MindShift: A New View of MS initiative to the 37th Annual QuickChek New Jersey Festival of Ballooning in Readington, NJ, on July 26-28, where the MS MindShift “Brain Bulb” hot air balloon will fly to raise awareness of multiple sclerosis (MS) and brain health.

July 24, 2019
·
5 min read
Business

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Third Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on August 5, 2019, at 4:30 p.m. EDT to discuss its financial results for the fiscal 2019 third quarter ended June 30, 2019.

July 24, 2019
·
2 min read